HCV相关肝细胞癌组织内HCV RNA及核心蛋白水平表达研究

肝脏 ›› 2021, Vol. 26 ›› Issue (2): 179-181.

HCV相关肝细胞癌组织内HCV RNA及核心蛋白水平表达研究

张波, 张余芬

214000 江苏无锡市第五人民医院肝病科

收稿日期:2020-04-25 出版日期:2021-02-28 发布日期:2021-03-28
通讯作者: 张余芬
基金资助:
2018年无锡市科协软科学研究课题(KX-18-B10)

The research of the expression of HCV RNA and core protein in the tissues of HCV-related hepatocellular carcinoma with bile duct tumor thrombus

ZHANG Bo, ZHANG Yu-fen

Department of Hepatology, The Fifth People's Hospital of Wuxi, Wuxi 214000, Jiangsu, China

Received:2020-04-25 Online:2021-02-28 Published:2021-03-28
Contact: ZHANG Yu-fen

摘要/Abstract

摘要： 目的研究丙型肝炎病毒(HCV)相关肝细胞癌组织内HCV RNA及核心蛋白表达的临床意义。方法纳入54例HCV相关肝细胞癌患者作为研究对象,检测HCV相关肝细胞癌癌组织和癌旁组织HCV RNA与HCV核心蛋白阳性率,比较癌组织与癌旁组织HCV RNA及HCV核心蛋白阳性率。比较不同分期、分化程度患者癌组织HCV RNA和HCV核心蛋白阳性率。结果癌组织与癌旁组织HCV RNA阳性率差异有统计学意义(P<0.05)。癌组织与癌旁组织HCV核心蛋白阳性率比较,差异显著(P<0.05)。HCV相关肝细胞癌癌组织内HCV RNA阳性率与HCV核心蛋白阳性率分布具有良好的一致性(Kappa值=0.951,P=0.000)。不同病理分期癌组织HCV RNA阳性率差异显著(P<0.05)。不同分化程度癌组织HCV RNA阳性率差异显著(P<0.05)。不同分期患者HCV核心蛋白阳性率差异显著(P<0.05)。不同分化程度癌组织HCV核心蛋白阳性率差异显著(P<0.05)。结论 HCV RNA及核心蛋白阳性率与HCV相关肝细胞癌发生相关,监测HCV RNA含量与HCV核心蛋白有助于HCV相关肝细胞癌的诊疗。

关键词: HCV相关肝细胞癌, 癌组织, HCV RNA, 核心蛋白

Abstract: Objective To study the clinical significance of the expression of hepatitis C virus (HCV) RNA and core protein in the tissues of hepatitis C virus (HCV)-related hepatocellular carcinoma.Methods Fifty-four patients of HCV-related hepatocellular carcinoma were included as the research subjects,the positive rates of HCV RNA and HCV core protein in the patients of HCV-related hepatocellular carcinoma of cancer tissue and paracancerous tissue were detected.The positive rates of HCV RNA and HCV core protein between cancer and adjacent tissues were compared,the positive rates of HCV RNA and HCV core protein in cancer tissues of patients with different stages and differentiation were compared. Results There was significant difference in the positive rate of HCV RNA between cancer tissue and adjacent tissue (P<0.05).There was significant difference in the positive rate of HCV core protein between cancer tissue and adjacent tissue (P<0.05).The distribution of HCV RNA positive rate and HCV core protein positive rate in the patients of HCV related hepatocellular carcinoma was consistent (Kappa value=0.951,P=0.000).The positive rate of HCV RNA was significantly different in different pathological stages (P<0.05).The positive rate of HCV RNA in different differentiated cancer tissues was significantly different (P<0.05).The positive rate of HCV core protein was significantly different in different stages (P<0.05).The positive rate of HCV core protein in different differentiated cancer tissues was significantly different (P<0.05).Conclusion The positive rate of HCV RNA and core protein are related to the occurrence of HCV-related hepatocellular carcinoma.It is helpful to the diagnosis and treatment of HCV-related hepatocellular carcinoma by monitoring the content of HCV RNA and core protein.

Key words: Hepatitis C virus-related hepatocellular carcinoma, Cancer tissue, HCV RNA, Core protein

张波, 张余芬. HCV相关肝细胞癌组织内HCV RNA及核心蛋白水平表达研究[J]. 肝脏, 2021, 26(2): 179-181.

ZHANG Bo, ZHANG Yu-fen. The research of the expression of HCV RNA and core protein in the tissues of HCV-related hepatocellular carcinoma with bile duct tumor thrombus[J]. Chinese Hepatolgy, 2021, 26(2): 179-181.

参考文献

[1] 严云青,王志良.转录因子Slug与KLF5相互作用及其对肝癌细胞迁移能力的影响.肝脏,2018,23:395-399.
[2] 刘爱祥, 王海清, 薄文滔,等.肝外胆管切除对肝细胞癌合并胆管癌栓患者的意义.中华肝胆外科杂志, 2018, 24:395-399.
[3] Oude Ophuis CMC, Louwman MWJ, Grünhagen DJ, et al.Implementation of the 7th edition AJCC staging system: Effects on staging and survival for pT1 melanoma. A dutch population based study.Int J Cancer, 2017, 140:1802-1808.
[4] Selitsky SR, Dinh TA, Toth CL, et al. Transcriptomic analysis of chronic hepatitis B and C and liver cancer reveals MicroRNA-Mediated control of cholesterol synthesis programs. mBio,2015,6:1500-1515.
[5] 柴嘉穗,王建,刘子荣,等.活化T细胞核因子在肝细胞癌组织中的表达及与临床病理因素的关系.中华肝胆外科杂志, 2019, 25:171-174.
[6] Yamamoto S, Hasegawa K, Inoue Y, et al. Bile duct preserving surgery for hepatocellular carcinoma with bile duct tumor thrombus.Ann Surg,2015,261:123-125.
[7] Wang M, Wang Y, Feng X, et al. Contribution of hepatitis B virus and hepatitis C virus to liver cancer in China north areas: experience of the Chinese national cancer center. Int J Dis, 2017,65:15-21.
[8] Ng TI, Tripathi R, Reisch T, et al. In vitro antiviral activity and resistance profile of the next-generation hepatitis C virus NS3/4A protease inhibitor glecaprevir.Antimicrob Agents Ch, 2017, 62:1620-1622.
[9] 李克田,沈明格,王凤荣, 等.血糖水平对原发性肝癌患者18F-FDG摄取和PET/CT检查图像质量的影响研究.实用肝脏病杂志,2019,22:256-259.
[10] Meuleman P,Earnest-Silveira L,Das S, et al.Characterisation of a hepatitis C virus like particle vaccine produced in a human hepatocyte-derived cell line.J General Virol, 2016, 97:1865-1876.
[11] Lunemann S, Martrus G, Angelique Hölzemer, et al. Sequence variations in HCV core-derived epitopes alter binding of KIR2DL3 to HLA-C 03:04 and modulate NK cell function. J Hepatol,2016,65:252-258.